本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

OncoMed Pharmaceuticals, Inc.

0.8900
+0.0000
成交量:- -
成交额:- -
市值:3,443.42万
市盈率:-4.22
高:0.8900
开:0.8900
低:0.8900
收:0.8900
数据加载中...
2019/04/26

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/24

员工持股计划

Securities to be offered to employees in employee benefit plans, post-effective amendments
2019/04/23

交易所摘牌声明

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2019/04/17

企业合并公告

Prospectuses and communications, business combinations
2019/03/15

企业合并公告

Prospectuses and communications, business combinations
2019/03/15

企业合并公告

Prospectuses and communications, business combinations
2019/03/12

企业合并公告

Prospectuses and communications, business combinations
2019/02/22

企业合并公告

Prospectuses and communications, business combinations
2019/02/15

企业合并公告

Prospectuses and communications, business combinations
2019/02/12

企业合并公告

Prospectuses and communications, business combinations
2019/02/11

企业合并公告

Prospectuses and communications, business combinations
2019/01/07

企业合并公告

Prospectuses and communications, business combinations
2018/12/26

SEC问询函

Statement of changes in beneficial ownership of securities
2018/12/11

企业合并公告

Prospectuses and communications, business combinations
2018/12/06

企业合并公告

Prospectuses and communications, business combinations